Investments
520Portfolio Exits
81Funds
20Service Providers
2About BlueRun Ventures
BlueRun Ventures (BRV) is an early stage venture firm focused on mobile opportunities in key global markets. Since inception, BlueRun has focused on working with mobile startups to shape the ever-evolving ecosystem. They choose key geographic markets where mobile is a driving force in the way consumers and businesses interact with each other. BlueRun has offices in Menlo Park, Beijing, Shanghai, and Seoul.
Want to inform investors similar to BlueRun Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing BlueRun Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find BlueRun Ventures in 1 Expert Collection, including Fitness Tech.
Fitness Tech
227 items
We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.
Research containing BlueRun Ventures
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BlueRun Ventures in 4 CB Insights research briefs, most recently on Jun 9, 2021.
Latest BlueRun Ventures News
Jan 2, 2023
LeadArt Biotechnologies , a Boston, MA and Ningbo, China-based biotechnology company focused on drug discovery by automating chemoproteomics processes, raised US$6M in Pre-A funding. The round was led by BlueRun Ventures Aster. The company intends to use the funds to advance the development of its automated chemoproteomics platform and the creation of a human target-probe database. Led by CEO Feng Ni, LeadArt Biotechnologies is accelerating drug discovery by automating chemoproteomics processes and creating a human live-cell target-probe database. Its platform integrates biotechnology and automation technologies to discover disease-related targets and chemical probes for traditionally undruggable and unexplored targets. The company recently signed a strategic collaboration with AstraZeneca’s iCampus to develop a herbal medicine preclinical translation platform in Chengdu, China. FinSMEs
BlueRun Ventures Investments
520 Investments
BlueRun Ventures has made 520 investments. Their latest investment was in Leadart Technologies as part of their Seed VC - II on December 12, 2022.
BlueRun Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/27/2022 | Seed VC - II | Leadart Technologies | $6M | Yes | 4 | |
12/14/2022 | Series A | Ruishi Health | $7.2M | Yes | 1 | |
11/24/2022 | Seed VC - II | Thin Red Line | $50M | No | 5 | |
11/21/2022 | Seed VC | |||||
10/21/2022 | Seed VC |
Date | 12/27/2022 | 12/14/2022 | 11/24/2022 | 11/21/2022 | 10/21/2022 |
|---|---|---|---|---|---|
Round | Seed VC - II | Series A | Seed VC - II | Seed VC | Seed VC |
Company | Leadart Technologies | Ruishi Health | Thin Red Line | ||
Amount | $6M | $7.2M | $50M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 4 | 1 | 5 |
BlueRun Ventures Portfolio Exits
81 Portfolio Exits
BlueRun Ventures has 81 portfolio exits. Their latest portfolio exit was Gennev on October 18, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/18/2022 | Acquired | 8 | |||
7/5/2022 | Acquired | 3 | |||
4/11/2022 | Acquired | 2 | |||
Date | 10/18/2022 | 7/5/2022 | 4/11/2022 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 8 | 3 | 2 |
BlueRun Ventures Fund History
20 Fund Histories
BlueRun Ventures has 20 funds, including BRV Healthcare Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/9/2019 | BRV Healthcare Fund | $497.2M | 1 | ||
1/16/2019 | BRV VI | Early-Stage Venture Capital | Closed | $130M | 8 |
12/31/2018 | BRV Aster Fund I | Early-Stage Venture Capital | Closed | 1 | |
12/31/2016 | BRV Aster Fund II | ||||
10/27/2016 | BlueRun China Fund IV |
Closing Date | 12/9/2019 | 1/16/2019 | 12/31/2018 | 12/31/2016 | 10/27/2016 |
|---|---|---|---|---|---|
Fund | BRV Healthcare Fund | BRV VI | BRV Aster Fund I | BRV Aster Fund II | BlueRun China Fund IV |
Fund Type | Early-Stage Venture Capital | Early-Stage Venture Capital | |||
Status | Closed | Closed | |||
Amount | $497.2M | $130M | |||
Sources | 1 | 8 | 1 |
BlueRun Ventures Service Providers
2 Service Providers
BlueRun Ventures has 2 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Counsel | General Counsel | ||
Service Provider | ||
|---|---|---|
Associated Rounds | ||
Provider Type | Counsel | |
Service Type | General Counsel |
Partnership data by VentureSource
BlueRun Ventures Team
11 Team Members
BlueRun Ventures has 11 team members, including current Founder, General Partner, John A. Malloy.
Name | Work History | Title | Status |
|---|---|---|---|
John A. Malloy | Founder, General Partner | Current | |
Name | John A. Malloy | ||||
|---|---|---|---|---|---|
Work History | |||||
Title | Founder, General Partner | ||||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.